Skip to main content

CTI Access Patient Assistance Program

CTI BioPharma Corp.

UnknownUnder review·Apr 26, 2026

CTI BioPharma Corp. is committed to helping patients, caregivers, and healthcare professionals access VONJO™(pacritinib) and the support they need. Specific types of financial assistance or eligibility requirements are not detailed on this page.

Covers
financial assistance
Enrollment cycle
unknown

Apply

Application goes directly to CTI BioPharma Corp.. RxCopays does not receive compensation.

Go to application →

Status source

Refer to our helpful list below for the numerous organizations providing financial support and assistance